Family Legacy Inc. Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Family Legacy Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 7,946 shares of the healthcare conglomerate’s stock after acquiring an additional 121 shares during the quarter. UnitedHealth Group accounts for 1.4% of Family Legacy Inc.’s holdings, making the stock its 28th largest holding. Family Legacy Inc.’s holdings in UnitedHealth Group were worth $4,168,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $40,000. Finally, Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $515.47 on Monday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company’s 50 day moving average is $508.81 and its two-hundred day moving average is $543.92. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $471.51 billion, a PE ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.